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a b s t r a c t
The yeast Saccharomyces cerevisiae is a widely used eukaryotic model organism and a key cell factory for
production of biofuels and wide range of chemicals. From the broad palette of available yeast strains, the
most popular are those derived from laboratory strain S288c and the industrially relevant CEN.PK strain
series. Importantly, in recent years these two strains have been subjected to comparative “-omics”
analyzes pointing out signiﬁcant genotypic and phenotypic differences. It is therefore possible that the
two strains differ signiﬁcantly with respect to their potential as cell factories for production of speciﬁc
compounds. To examine this possibility, we have reconstructed a de novo vanillin-β-glucoside pathway in
an identical manner in S288c and CEN.PK strains. Characterization of the two resulting strains in two
standard conditions revealed that the S288c background strain produced up to 10-fold higher amounts of
vanillin-β-glucoside compared to CEN.PK. This study demonstrates that yeast strain background may
play a major role in the outcome of newly developed cell factories for production of a given product.
& 2015 Published by Elsevier B.V. on behalf of International Metabolic Engineering Society.
1. Introduction
The recent achievements in the ﬁeld of systems biology and
metabolic engineering combined with a wide array of molecular
biology tools has established the yeast Saccharomyces cerevisiae as
a key cell factory for heterologous production of scientiﬁcally and
industrially relevant products. The latter comprise a large variety
of products ranging from low-value bulk chemicals and biofuels
(e.g., ethanol) to food additives (e.g., ﬂavors and colorants) and
high value pharmaceuticals (e.g., recombinant proteins) (Kim
et al., 2012; Hong and Nielsen, 2012). Today, a range of different S.
cerevisiae strain backgrounds are available for the yeast commu-
nity of which BY (S288c), W303 and CEN.PK are the most fre-
quently used (van Dijken et al., 2000). The variety of strains has
been developed by different laboratories to suit a range of diverse
research goals within different disciplines such as genetics, phy-
siology and biochemistry. For example, CEN.PK strain (Entian and
Kötter, 2007), is a popular platform for physiological as well as
metabolic engineering studies whereas S288c, the ﬁrst eukaryote
to be sequenced (Goffeau et al., 1996), was mainly used for genetic
studies, but has in recent years been increasingly used as an al-
ternative platform for metabolic engineering experiments (Kim
et al., 2012; Hong and Nielsen, 2012). Speciﬁcally, recent surveys
show that over the past ten years the two strains were used in
more than 50% of the analyzes with CEN.PK series being the most
popular (approx. 37%-CEN.PK vs. 24%-S288c and its derivatives)
(Kim et al., 2012; Hong and Nielsen, 2012). The importance of the
two strains as cell factories is further substantiated by an extensive
multi-laboratory efforts which were made for systematic com-
parisons of S288c and CEN.PK (Rogowska-Wrzesinska et al., 2001;
Canelas et al., 2010). Genetic differences of these strains were re-
vealed ﬁrst by microarray studies (Daran-Lapujade et al., 2003)
and more recently genotype to phenotype relation was in-
vestigated after whole-genome sequencing of the CEN.PK113-7D
strain (Otero et al., 2010; Nijkamp et al., 2012). For example, the
sequencing comparison studies revealed that 83 genes were ab-
sent in CEN.PK relative to S288C (Nijkamp et al., 2012) and that
more than 22,000 single nucleotide polymorphisms (SNPs) exist
between the two strains. 13,000 of the SNPs are distributed in
1843 open reading frames (ORFs) and the activity of a large
number of proteins may therefore differ in the two strains; espe-
cially since 35% of these SNPs result in amino-acid residue sub-
stitutions. The remaining 9000 SNPs, which are mainly distributed
in the intergenic regions, may potentially impact gene expression
and thereby protein levels in the two strains. The fact that the
highest enrichment of SNPs was detected in genes involved in
carboxylic acid, organic acid, and carbohydrate metabolism, as
well as, in nitrogen, amino acid, lipid and aromatic compound
metabolism suggests that the basic metabolism in the two strain
background may be quite different (Otero et al., 2010). Im-
portantly, based on the combined “-omics” analyzes, several
phenotypic differences between the two strains were assigned to
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these mutations, e.g., differences in galactose uptake and ergos-
terol biosynthesis, etc. in two strains (Otero et al., 2010).
The fact that the two main S. cerevisiae backgrounds for con-
struction of cell factories are genetically/phenotypically quite dif-
ferent raises the possibility that heterologous production of a gi-
ven compound in CEN.PK and in S288c may result in signiﬁcantly
different yields. To examine this possibility, we therefore con-
structed comparable cell factories for vanillin-β-glucoside (VG)
production in S288c and CEN.PK backgrounds. Importantly, all ﬁve
relevant genes for VG production in S. cerevisiae, (see Fig. 1 and
Hansen et al. (2009)) were integrated at phenotypically neutral
and well deﬁned locations in the yeast chromosome using a re-
cently published integration platform (Mikkelsen et al., 2012).
Moreover, in order for the engineered strains to be directly com-
parable, auxotrophies were eliminated by a sexual backcross to the
corresponding wild-type strains. Remarkably, the physiological
characterizations of both VG cell factories in two different culti-
vation modes revealed major differences in the VG production.
Next, we examined the comprehensive “-omics” datasets for S288c
and CEN.PK strains (Canelas et al., 2010) to look for plausible
reasons for the different VG production proﬁles in the two genetic
backgrounds. Together our analyzes serve as a step towards a
scenario where the optimal genetic background for cell factory
construction can be successfully selected based on a systems
biology model for yeast cell factories.
2. Materials and methods
2.1. DNA cloning procedures
The DNA fragments used for vector construction were
ampliﬁed by PCR with PfuX7 polymerase developed by Nørholm
(2010) using the primers listed in the Table 1. Molecular coning
was done by uracil-speciﬁc excision reagent (USER™) as pre-
viously described in (Geu-Flores et al., 2007; Nour-Eldin et al.,
2006). Final constructs were validated by sequencing (StarSEQ
s
GmbH, Germany). The genes constituting the de novo VG pathway
(1-3DSD, 2-ACAR, 3-EntD, 4-HsOMT, and 5-UGT) and a set of bi-
directional promoter (pPGK1/pTEF1) were ampliﬁed by PCR from
the appropriate vector templates (see Table 2). The pathway genes
and promoters were assembled into vectors designed to integrate
on chromosome XII (Mikkelsen et al., 2012). A total of three
plasmids were produced: pXII1-23 (pPGK1::ACAR; pTEF1::EntD),
pXII2-54 (pPGK1::UGT; pTEF1::HsOMT) and pXII5-01
(pTEF1::3DSD), see Fig. S1. For a full list of plasmids used or con-
structed in this work see Table 2.
2.2. Strain construction
The genotype and source of the strains used in this study is
given in the Table 3. Two different background strains CEN.PK113-
11C and X2180-1A (isogenic to S288c (Mortimer and Johnston,
1986)) were used as hosts for reconstruction of the de novo va-
nillin-β-glucoside (VG) pathway. All yeast constructs were gener-
ated by high efﬁciency transformation method (lithium acetate/
polyethylene glycol/single carrier DNA) previously described
by Gietz et al. (1992).
To construct two yeast strains containing the VG pathway,
vectors pXII1-23, pXII2-54 and pXII5-01 harboring the following
genes (ACAR and EntD), (UGT and HsOMT) and (3DSD), respectively,
were digested with NotI restriction enzyme (Fermentas-Thermo
Fisher Scientiﬁc) and gel-puriﬁed using illustra GFX PCR DNA and
Gel Band Puriﬁcation Kit (GE Lifesciences). The individual gene
Fig. 1. De novo vanillin-β-glucoside pathway in S. cerevisiae assembled by Hansen et al. (2009). Colored boxes represent metabolites of the pathway: PAC – protocatechuic
acid, PAL – protocatechuic aldehyde, VAC – vanillic acid, VAN – vanillin, VG – vanillin-glucoside. Black thick arrows show enzymatic reactions by heterologous enzymes:
3DSD – 3-dehydroshikimate dehydratase (Podospora pauciseta), ACAR – aromatic carboxylic acid reductase (Neurospora sp.), EntD – phosphopantetheine transferase (Es-
cherichia coli), HsOMT – O-methyltransferase (Homo sapiens) and UGT – UDP-glycosyltransferase (Arabidopsis thaliana). Gray arrows and boxes (left side of the picture)
represent simpliﬁed shikimate biosynthetic pathway and native parts of yeast metabolism: PPP – pentose phosphate pathway, DAHP – 3-deoxy-D-arabinoheptulosonate
7-phosphate, 3-DHS – 3-dehydroshikimic acid, Trp – tryptophan, Phe – phenylalanine, Tyr – tyrosine. Key enzymes of the shikimate pathway: ARO3 and ARO4 – DAHP
synthase isoenzymes and ARO1 – pentafunctional enzyme catalyzing DAHP conversion to chorismate.
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targeting substrates were transformed iteratively into both yeast
strain backgrounds in three consecutive transformations. To pre-
vent undesired production of toxic intermediates especially pro-
tocatechuic aldehyde (PAL), the 3DSD gene was cloned at the latest
step. After each round of transformation the URA3 marker was
eliminated by direct repeat recombination and counter-selection
on 5-FOA (Boeke et al., 1984) allowing the URA3 marker to be
recycled.
Complete gene deletions of BGL1 and ADH6 were achieved
using method described by Güldener et al. (1996). PCR fragment
carrying loxP-KanMX-loxP ﬂanked by 40nt long segment homo-
logous to sequences of Up- and Down-stream of the appropriate
open reading frame (ORF) to be deleted were ampliﬁed form
plasmid pUG6. The KanMX marker was excised by expressing Cre
recombinase from the vector pSH47 (Güldener et al., 1996). All
gene targeting events were validated by diagnostic PCR using
specially designed primer pairs (see Table 1).
To eliminate any auxotrophies, two engineered strains S-VG-
aux and C-VG-aux were sexually crossed to S288c and CEN.PK110-
16D, respectively. This resulted in two ﬁnal prototrophic vanillin-
β-glucoside producing yeast strains S-VG (S288c based) and C-VG
(CEN.PK based). Genetic cross and selection procedures were
performed as described in (Treco and Winston, 2008). Schematic
ﬂowchart representing the strain construction is depicted in Fig.
S2.
2.3. Media
For cloning purposes lysogeny broth (LB) (Bertani, 1951) sup-
plemented with 100 mg/L of ampicillin (Sigma-Aldrich) was used
for growing of Escherichia coli DH5α.
All media used for genetic manipulations of yeast were pre-
pared as previously described by Sherman et al. (1986), with
minor modiﬁcations of synthetic medium where leucine con-
centration was doubled to 60 mg/L. All yeast transformants with
gene integrations were selected on synthetic complete media
missing uracil (SC-ura). For subsequent round of transformations
Table 1
List of the primers used in this study. All sequences are presented in 5′–3′ direction, standard capital letter are gene speciﬁc sequences, bold letters represent USER speciﬁc
tails, regular underline letters represent targeting sequences for appropriate gene deletions. Italic letters represent translational enhancer sequence (Nakagawa et al., 2008;
Cavener and Ray, 1991).
Name Sequence
Primers for cloning purposes
PGK_R- ACCCGTTGAUGCCGCTTGTTTTATATTTGTTG
TEF_Fþ CGTGCGAUGCCGCACACACCATAGCTTC
TEF_Rþ ACGTATCGCUGTGAGTCGTATTACGGATCCTTG
DSD_Fþ AGCGATACGUAAAAATGCCTTCCAAACTCGCC
DSD_Rþ CACGCGAUTTACAAAGCCGCTGACAGC
ACAR_F- ATCAACGGGUAAAAATGGCTGTTGATTCACCAGATG
ACAR_R- CGTGCGAUCTTATAACAATTGTAACAATTCCAAATC
hOMT_Fþ AGCGATACGUAAAAATGGGTGACACTAAGGAGCAA
hOMT_Rþ CACGCGAUCTTATGGACCAGCTTCAGAACC
PPT1_Fþ AGCGATACGUAAAAATGGTCGATATGAAAACTACGC
PPT1_Rþ CACGCGAUTTAATCGTGTTGGCACAGC
UGT1_F- ATCAACGGGUAAAAATGCATATCACAAAACCACACG
UGT1_R- CGTGCGAUACTAGGCACCACGTGACAAGTC
Deletion primers
BGL1_del_F ATTTTTTGTTTACTTTCTTTTTCTAGTTAATTACCAACTAAACTTCGTACGCTGCAGGTC
BGL1_del_R CATTAGAAAATTCAGCTAAAATGAGCGGACTGAGGGCGACTAGTGGATCTGATATCACCTA
ADH6_del_F GAGGAAGAAATTCAACACAACAACAAGAAAAGCCAAAATCCTTCGTACGCTGCAGGTC
ADH6_del_R GTTAAAAAGAAAGGAGCTACATTTATCAAGAGCTTGACAACTAGTGGATCTGATATCACCTA
Veriﬁcation primers
XII-1-up-out-sq CTGGCAAGAGAACCACCAAT
XII-2-up-out-sq CGAAGAAGGCCTGCAATTC
XII-5-up-out-sq CCACCGAAGTTGATTTGCTT
C1_TADH1_F CTTGAGTAACTCTTTCCTGTAGGTC
BGL1_VF TCATCCTCCCTGTGTTTACA
BGL1_VR AGTTGAAACAGAGGATAAGGTG
ADH6_VF GTTTTGCTTTTTTCTCTGGG
ADH6_VR GGAGTATCAACCACTAAAGCG
Primers for sequencing
S1_TEF_F CGGTCTTCAATTTCTCAAGTTTC
S1_PGK_F CAAGGGGGTGGTTTAGTTTAGT
S1_ACAR_F CATTGTTCGTTCCAGACACTGAC
S2_ACAR_F GAAATTGTCTCAAGGTGAGTTCG
S3_ACAR_F TTTGGGTAGATTCTTGTGTTTGG
YF19 AAAAAATAAATAGGGACCTAGACTTCA
YF21 GACCTACAGGAAAGAGTTACTCAAGAAT
Table 2
List of the plasmids used and constructed in this study.
Name Genetic element Reference
pXII1–23 pPGK1::ACAR, pTEF1::EntD This study
pXII2–54 pPGK1::UGT, pTEF1::HsOMT This study
pXII5–01 pTEF1::3DSD This study
pXII1  Mikkelsen et al. (2012)
pXII2  Mikkelsen et al. (2012)
pXII5  Mikkelsen et al. (2012)
pSP–G2 pPGK1;pTEF1 Partow et al. (2010)
pJH500 3DSD Hansen et al. (2009)
pJH674 ACAR Hansen et al. (2009)
pJH589 EntD Hansen et al. (2009)
pJH543 HsOMT Hansen et al. (2009)
pJH665 UGT Hansen et al. (2009)
pUG6 KanMX Güldener et al. (1996)
pSH47 Cre recombinase Güldener et al. (1996)
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URA3 marker was recycled through direct repeat recombination
and selected on synthetic complete media containing 30 mg/L
uracil and 740 mg/L 5-ﬂuoroorotic acid (5-FOA) (Sigma-Aldrich).
Yeast transformants with necessary gene deletions were se-
lected on Yeast Extract Peptone Dextrose (YPD) plates supple-
mented with 200 mg/L of G418 (Sigma-Aldrich) (Güldener et al.,
1996). The medium composition is as follows: 10 g/L of yeast ex-
tract, 20 g/L of peptone and 20 g/L of glucose and 20 g/L of agar.
A deﬁned minimal medium previously described by Verduyn
et al. (1992) with glucose as a carbon source was used for S. cer-
evisiae cultivations in batch and chemostat cultures. For batch
cultivations the medium was supplemented with 30 g/L of glucose
(Canelas et al., 2010), whereas for feed media for continuous cul-
tivations contained 7.5 g/L of glucose. The medium was composed
of: 7.5 g/L (NH4)2SO4, 3 g/L KH2PO4, 0.75 g/L Mg2SO4, 1.5 mL/L
trace metal solution, 1.5 mL/L vitamins solution, 0.05 mL/L anti-
foam 204 (Sigma-Aldrich). Trace metal solution contains 3 g/L
FeSO4 7H2O, 4.5 g/L ZnSO4 7H2O, 4.5 g/L CaCl2 6H2O, 0.84 g/L
MnCl2 2H2O, 0.3 g/L CoCl2 6H2O, 0.3 g/L CuSO4 5H2O, 0.4 g/L
NaMoO4 2H2O, 1 g/L H3BO3, 0.1 g/L KI and 15 g/L Na2EDTA 2H2O.
Vitamins solution includes 50 mg/L D-biotin, 200 mg/L para-amino
benzoic acid, 1.0 g/L nicotinic acid, 1.0 g/L Ca-pantothenate, 1.0 g/L
pyridoxine HCL, 1.0 g/L thiamine HCl and 25 mg/L minositol. Glu-
cose was autoclaved separately and vitamins solutions were sterile
ﬁltered (pore size 0.2 μm Ministarts-Plus, Sartorius AG, Germany)
and added after autoclavation.
2.4. Batch and chemostat cultivations
For each biological replica separate colonies of engineered
yeast strains from YPD plate were inoculated to the 0.5 L shake
ﬂasks with 50 mL of the previously described minimal medium
(pH 6.5). Pre-cultures were incubated in an orbital shaker set to
150 rpm at 30 °C until mid-exponential phase OD600E5 and di-
rectly used for inoculation. In this experiment, batch cultivations
were performed in duplicates and continuous cultures – in
triplicates.
Batch cultivations were performed under aerobic conditions in
1 L fermenters equipped with continuous data acquisition (Sar-
torius, B. Braun Biotech International, GmbH, Melsungen, Ger-
many) with a working volume of 1 L. Fermenters were inoculated
with initial O.D.600¼0.05. To ensure aeration a stirrer speed was
set to 600 rpm and airﬂow rate to 1.0 v.v.m. (60 L/h). The tem-
perature was maintained at 30 °C during the cultivation and
pH¼5.0 level was controlled by automatic addition of 2 M NaOH
or 2 M H2SO4. The batch cultures were sampled in regular intervals
through both glucose and ethanol growth phases. Glucose-limited
chemostat cultures were grown in the same conditions as
previously described for batch cultivations. Chemostats were in-
itiated as batch cultivations with starting glucose concentration of
15 g/L and OD600¼0.05 and switched to continuous mode in early
exponential phase. Minimal mediumwas fed at a constant dilution
rate of 0.1 h1 (Canelas et al., 2010). The working volume of 1 L
was kept constant by a level based outlet. Samples were taken
after at least ﬁve residence times (50 h) of constant biomass and
carbon dioxide concentration readings.
In both cultivation experiments exhaust gas composition was
constantly monitored by off gas analyzer (1311 Fast response triple
gas, Innova) combined with Mass Spectrometer (Prima Pro Process
MS, Thermo Fisher Scientiﬁc, Winsford UK). No elevated ethanol
concentration in the exhaust was detected.
The biomass concentration was monitored by measuring both
optical density at 600 nm wavelength (OD600) and cell dry weight
(DW) in the cultivation broth. OD600 was estimated using a UV
mini 1240 spectrophotometer (Shimadzu, Kyoto, Japan), biomass
samples were diluted with distilled water to achieve OD600 read-
ing within 0.1–0.4 range. DW measurements were performed
using polyethersulfone (PES) ﬁlters with a pore size of 0.45 μm
Montamil
s
(Membrane Solutions, LLC). The ﬁlters were pre-dried
in a microwave oven at 150 W and weighed. A known volume of
cultivation broth (5 mL) was ﬁltered and then washed with ap-
prox. 15 mL of distilled water. Finally, the ﬁlters with biomass were
dried in the microwave oven at 150 W and cell DW was de-
termined (Olsson and Nielsen, 1997).
2.5. Extracellular metabolite measurements
Extracellular metabolites were determined by high perfor-
mance liquid chromatography (HPLC) analysis. Two distinct HPLC
methods were applied for analysis of different groups of extra-
cellular metabolites.
The submerged cultivation samples for yeast primary meta-
bolites were centrifuged at 12,000g for 2 min, supernatant was
transferred to a new tube and stored at 20 °C until further
analysis. Glucose, ethanol, glycerol, pyruvate, succinate and acetate
were determined by high performance liquid chromatography
(HPLC) analysis using an Aminex HPX-87H ion-exclusion column
(Bio-Rad Laboratories, Hercules, CA). The column temperature was
kept at 60 °C and the elution was performed using 5 mM H2SO4
with constant ﬂow rate of 0.6 mL min1. Metabolite detection was
performed by a RI-101 differential refractometer detector (Shodex)
and an UVD340U absorbance detector (Dionex) set at 210 nm.
Samples for quantiﬁcation of vanillin-β-glucoside and its
pathway metabolites were prepared as follows: 1 mL of cultivation
broth and 1 mL of 96% EtOH was carefully mixed by vortex and
centrifuged at 12,000g for 2 min, supernatant was transferred to a
Table 3
List of the yeast strains used in this study.
Name Genotype Reference
X2180-1A (ura3) MATa SUC2 mal mel gal2 CUP1 ura3-52 Public domain (Mortimer and Johnston,
1986)
S288c MATα SUC2 gal2 mal mel ﬂo1 ﬂo8-1 hap1 ho bio1 bio6 ATCC 204508
CEN.PK113-11C MATa MAL2-8C SUC2 ura3-52 his3Δ Peter Köttera
CEN.PK110-16D MATα MAL2-8C SUC2 trp1-289 Peter Köttera
C-VG-aux MATa MAL2-8C SUC2 ura3-52 his3Δ XII2(pTEF1-HsOMT, pPGK1-UGT) XII1(pTEF1-PPT, pPGK1-ACAR) XII5
(pTEF1-3DSD) Δbgl1::loxP Δadh6::KanMX
This study
S-VG-aux MATa SUC2 gal2 mal mel ura3-52 XII2(pTEF1-HsOMT, pPGK1-UGT) XII1(pTEF1-PPT, pPGK1-ACAR) XII5
(pTEF1-3DSD) Δbgl1::loxP Δadh6::KanMX
This study
C-VG MATα MAL2-8C SUC2 XII2(pTEF1-HsOMT, pPGK1-UGT) XII1(pTEF1-PPT, pPGK1-ACAR) XII5(pTEF1-3DSD)
Δbgl1::loxP Δadh6::KanMX
This study
S-VG MATα SUC2 gal2 mal mel XII2(pTEF1-HsOMT, pPGK1-UGT) XII1(pTEF1-PPT, pPGK1-ACAR) XII5(pTEF1-3DSD)
Δbgl1::loxP Δadh6::KanMX
This study
a Institut für Mikrobiologie, der Johan Wolfgang Goethe-Universität, Frankfurt am Main, Germany.
T. Strucko et al. / Metabolic Engineering Communications 2 (2015) 99–108102
new tube and stored at 20 °C until further analysis. Extracellular
vanillin-β-glucoside (VG), vanillin (VAN), protocatechuic acid
(PAC), protocatechuic aldehyde (PAL) and vanillic acid (VAC) were
quantiﬁed using Agilent 1100 series equipment with a Synergi
Polar-RP 1502 mm 4 m column (Phenomenex). A gradient of
acetonitrile (ACN) with 1% tetra-ﬂuoroacetic acid (TFA) and water
with 1% TFA at a constant ﬂow rate of 0.5 mL/min was used as
mobile phase. The elution proﬁle was as follows: 5% ACN – 1 min,
5% ACN to 30% ACN – 8 min, 30% ACN to 100% ACN – 1 min, 100%
ACN — 1 min, 100% ACN to 5% ACN – 3 min. The column was kept
at 40 °C and metabolite detection was performed using a UV
diode-array detector set to 230 and 280 nm.
2.6. Intracellular metabolite measurements
Samples for intracellular co-factor metabolites were taken
during steady state conditions at the end of continuous cultivation.
The samples were quenched and extracted as previously described
by Villas-Bôas et al. (2005); 5 mL of culture broth was sprayed into
pre-cooled (40 °C) falcon tube containing 20 mL of 60% metha-
nol, spun down for 2 min at 5000g in precooled centrifuge
(10 °C) and extracted using boiling ethanol method (Villas-Bôas
et al., 2005) followed by evaporation under nitrogen. The samples
were re-dissolved in 300 mL eluent A (10 mM tributylamine and
10 mM acetic acid). The analysis was carried out on an Agilent
1290 binary UHPLC system coupled with an Agilent 6460 triple
quadrupole mass spectrometer (Torrance, CA, USA). The MS was
operated in negative ion and multiple reactions monitoring mode.
Separation of 0.5 mL samples was performed by ion-pair chroma-
tography, as described in detail in Magdenoska et al. (2013) using
10 mM tributylamine as ion pair reagent. The gradient used was:
0–12 min 0–50% B, 12–12.5 min 50–100% B, 12.5–14 min 100% B,
14–14.5 min 100–0% B, 14.5–19.5 min 0% B. External standard ca-
libration method was used for quantiﬁcation. The calibration
curves were constructed by preparing calibration solutions ran-
ging from 1 to 100 mg/mL for ATP and 0.3–25 mg/mL for NADPH
and UDP-glucose. Both the quenched extracts and the calibration
solutions were spiked with 60 mL mixture containing 150 mg/mL
[U13C] ATP. The quantiﬁcation was carried out using Mass
Hunter Quantitative analysis software (version B.06.00).
3. Results
3.1. De novo pathway reconstruction in CEN.PK and S288c
backgrounds
To compare CEN.PK and S288c for their ability to produce VG in
a fair manner, it was necessary to insert all genes identically in
both strain backgrounds. In the original VG producing strain, the
individual genes of the pathway were inserted by repeated in-
tegrations into the TPI1 promoter region in an S288c based strain
(Hansen et al., 2009). Consequently, the gene order is ill-deﬁned
and not easy to reconstruct in CEN.PK. We therefore introduced
the VG pathway in the two strain backgrounds, S288c (isogenic
isolate X2180-1A (Mortimer and Johnston, 1986)) and CEN.PK113-
11C (Entian and Kötter, 2007) in a deﬁned manner. Speciﬁcally, the
ﬁve genes used by Hansen et al. (2009) for VG production were
integrated into three sites located on chromosome XII (see Fig. 2),
which are part of a deﬁned gene expression platform we have
previously established (Mikkelsen et al., 2012). Importantly, prior
to integration, we compared the up- and downstream sequences
at these integration sites in CEN.PK and S288c and found that they
differ by only a single SNP, a C in CEN.PK and G in S288c, which is
present in the upstream targeting sequence of the XII-5 site. The
ﬁve genes are therefore inserted into a genetic context, which is
essentially identical. Additionally, two genes ADH6 and BGL1 were
deleted in both strains to minimize unwanted side reactions with
VG pathway metabolites. Finally, for both genetic backgrounds,
auxotrophic markers were eliminated by sexual back crossing to
wild-type variants of the two strain backgrounds to produce two
prototrophic VG producing strains, C-VG (CEN.PK based) and S-VG
(S288c based), which we used for further analysis.
3.2. Physiological characterization of vanillin-β-glucoside producing
strains during batch and continuous fermentations
Before evaluating the VG production ability of the two strain
backgrounds, we ﬁrst assessed whether VG production affected
the overall physiology of the C-VG and S-VG strains. Hence, they
were grown in batch and as continuous cultures in well-controlled
bioreactors under standard laboratory cultivation conditions (Ca-
nelas et al., 2010). Like for wild-type strains, the overall growth
proﬁles exhibited by the S-VG and C-VG strains in batch reactors
were composed by two growth phases. One initial growth phase
where all glucose was fermented (GF – phase); followed, after the
diauxic shift, by a second growth phase where all accumulated
ethanol was respiro-fermented (ER – phase), see Fig. 3. We note
that the speciﬁc biomass yield on glucose (Table 4) appeared
higher (14%) in C-VG as compared to S-VG, but in our experiment
this difference was not signiﬁcant (p40.33). A similar difference
has previously been observed for the parental S288c and CEN.PK
strains grown at the same conditions (van Dijken et al., 2000;
Canelas et al., 2010). It has previously been shown that CEN.PK
grows faster than S288c at these conditions, μmaxE0.4 h1 vs.
μmaxE0.3 h1, respectively (Canelas et al., 2010; Otero et al.,
2010). In contrast, C-VG and S-VG grew slower than the corre-
sponding wild-type strains and both strains displayed identical
growth rates on glucose (μmaxE0.2 h1). Further analysis of the
cultivation broth obtained at different time points during growth,
showed that the production proﬁles of ﬁve primary metabolites
(ethanol, pyruvate, succinate, glycerol, and acetate) in the central
carbon metabolism of S-VG and C-VG were similar to what has
previously been observed with the corresponding wild-type
strains (Fig S3). Among the remaining parameters – rGlc, rEth, and
rGly, only the latter varied between the two strains as it was ap-
prox. three-fold higher in the S-VG (po0.002). Finally, we also
note that S-VG displayed a growth deﬁciency during the ER phase
which was nearly twice as long with S-VG (23 h) than with C-VG
(12 h) partly due to a much longer delay from the diauxic shift to
exponential growth is resumed. This deﬁciency has also been
previously reported for wild-type S288c (Otero et al., 2010).
In chemostats, steady-state conditions with constant produc-
tion of biomass as well as stable readings of carbon dioxide and
oxygen by the off-gas analyzer where obtained for both strain
1 2 3 4 5
P2T1 T2P1ACAR EntD P2 T23DSD
P2T1 T2P1UGT HsOMT
Chr. XII
Fig. 2. Schematic representation of VG pathway reconstruction in two different S.
cerevisiae background strains. T1, T2 – terminators of ADH1 and CYC1, respectively;
P1, P2 – promoters of PGK1 and TEF1, respectively. Red arrows represent essential
genetic elements of S. cerevisiae and numbered yellow boxes are integration sites
characterized by Mikkelsen et al. (2012). (For interpretation of the references to
color in this ﬁgure legend, the reader is referred to the web version of this article.)
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backgrounds. For the C-VG strain this was achieved in less than
5 residence times (50 h) after feeding was initiated, whereas for
the S-VG strain it took more than 8 residence times (80 h), see Fig
S4. Importantly, at a dilution rate of 0.1 h1, both strains propa-
gated exclusively by glucose respiratory metabolism (Van Hoek,
1998) as no production of ethanol, glycerol and organic acids was
observed (see Table 4). The C-VG strain produced signiﬁcantly
more (seven percent, po0.01) biomass as compared to S-VG, on
the contrary, the speciﬁc glucose uptake rate was approx. seven %
higher (po0.01) in S-VG strain.
3.3. High VG yields with S288c are generated during its prolonged
ethanol respiratory growth phase
VG production in the S-VG and C-VG strains was initially
compared at 45 h after both cultures have reached stationary
phase. In the original VG producing strain constructed by Hansen
et al. (2009), various levels of intermediates were observed due to
an unbalanced heterologous VG pathway (Hansen et al., 2009) ,
(Brochado et al., 2010). In agreement with this, analyzes of the
extracellular metabolite levels in the cultivation broth showed that
PAC, PAL, VAC, and VAN accumulated in both S-VG and C-VG in
batch cultivation. The yields of each of the intermediates were
similar in the two strains (Fig. 4) with PAC being by far the most
prominent metabolite. In fact, PAC accounted for 70- and 75% of
the carbon ending up as intermediates in C-VG and S-VG strains,
respectively. However, when the two strains were analyzed for VG
production, we surprisingly observed that twice as much VG was
produced with the S-VG strain than with the C-VG strain
(po0.05). This ﬁnding prompted us to determine and compare
the production of VG and its intermediates of the two strains
during the different growth phases throughout the entire batch
cultivation (Fig. 5A and B). The VG yields were almost identical
with the two strains during the GF phase (Fig. 5C). The total carbon
ending up in VG pathway metabolites (TCV) is 14% lower in C-VG
as compared to S-VG. This effect is mainly due to less accumulated
PAC in C-VG (37% less in C-VG, po0.05). In contrast, with S-VG, a
two-fold higher (po0.05) VG yield was generated during the ER
phase than with C-VG despite that the amounts of intermediates
accumulating at the end of the phase were similar in both strains
(see Fig. 5C). As a result, TCV was 45% higher with S-VG as com-
pared to C-VG. Yields and productivities on glucose during ex-
ponential growth and during steady state condition are re-
presented in the Table S1).
To further understand why VG yields were higher with S-VG
than with C-VG, we determined whether production of VG and
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Fig. 3. Growth proﬁles of the two strains in the batch cultures: (a) S-VG and (b) C-VG. Gray areas represent ethanol respiration (ER) phase; GF – glucose fermentation. qCO2 –
carbon dioxide production rate, qO2 – oxygen consumption rate; Glc – glucose, Eth – ethanol and DW – cell dry weight. Error bars represent standard deviation, n¼2.
Table 4
Physiologic parameters of the two engineered strains. Ysx – biomass yield on glu-
cose, r – speciﬁc metabolite production or consumption rates (C-mmol/g(DW) h);
Glc –glucose, Eth – ethanol and Gly – glycerol. NA – not applicable and ND – not
detected. The yield coefﬁcient Ysx for biomass is calculated based on a molecular
weight for biomass of 26.4 g/C-mol (Lange and Heijnen, 2001). Errors represent
standard deviation, 2rnr3.
Cultivation mode Batch Chemostat
Strain S-VG C-VG S-VG C-VG
Glucose μ, h1 0.20970.002 0.19970.002 (0.1)n (0.1)n
Ethanol μ, h1 0.0570.01 0.0870.01 NA NA
Ysx (C-mol/C-mol) 0.13370.014 0.15170.001 0.5670.02 0.6070.02
-rGlc 60.778.0 49.970.60 6.8170.29 6.3770.20
rEth 25.973.1 20.973.00 ND ND
rGly 4.0570.05 1.4070.13 ND ND
n The dilution rate used in this study.
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Fig. 4. Final yields (45 h after inoculation) of VG, its intermediates, and TCV pro-
duced by S-VG (blue) and C-VG (yellow) during batch cultivation. Error bars re-
present standard deviation, n¼2. (For interpretation of the references to color in
this ﬁgure legend, the reader is referred to the web version of this article.)
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VG-intermediates was proportional to biomass during all time-
points. Based on this analysis, we observed for both strains that
the efﬁciencies of TCV, VAC and VG production were higher in the
ER phase as compared to the GF phase. In contrast, for both strains
PAC was produced with equal efﬁciency in the two phases Fig. 6.
After the diauxic shift, C-VG quickly entered a new state where
these metabolites were produced in amounts proportional to
biomass. With S-VG such states are also achieved for TCV, PAC and
VAC although, for TCV and VAC, more time was required for these
states to be reached in this strain as compared to C-VG. In contrast,
with S-VG a state where VG was produced proportionally to bio-
mass was never achieved as the VG production efﬁciency in-
creased during the entire phase, see Fig. 6D.
3.4. Steady-state VG production at glucose limitation is higher in
S288c than in CEN.PK
Next, we investigate VG production in continuous cultures
where we could obtain strictly glucose respiratory conditions for
both strains, see above. Dramatically, this analysis revealed that
the amounts of TCV and VG were signiﬁcantly increased to levels
four- and ten-fold higher with S-VG than with the C-VG strain
(po9E9, po2E10, respectively), see Fig. 7. When the levels of
intermediates were inspected, we observed that with S-VG, the
majority (68%) of the TCV ended up in VG, whereas the rest of the
carbon ended up in PAC (18%) and in VAC (13%). In contrast, VG
constituted only 20% of the TCV in the C-VG strain. The remaining
carbon was mainly ending up in VAC (approx. 70%) and only little
(less than 5%) in PAC.
Four co-factors, ATP, NADPH, SAM and UDP-Glc, are used for
formation of VG. In the paper by Canelas et al. (2010) where
“-omics” data for the two background strains were compared, the
levels of three of these cofactors (ATP, NADPH and UDP-Glc) were
measured. We were able to quantify ATP and therefore determined
the concentrations of this metabolite in C-VG and S-VG to in-
vestigate whether ATP levels were altered due to the presence of
the VG pathway. Analysis of samples obtained at steady state
showed that concentrations of ATP were 10.6 mmol/g DW and
8.5 mmol/g DW for C-VG and S-VG, respectively. These numbers are
somewhat higher than the corresponding numbers reported by
Canelas et al. and this may be due to lab to lab differences. Im-
portantly, the relative ATP levels of the two strains (C-VG to S-VG)
is 1.2 in our experiment as well as in theirs (Canelas et al., 2010).
This indicates that the presence of the VG pathway does not
change ATP levels in the two strains despite that 10-fold more VG
is formed in S-VG as compared in to C-VG. Due to the absence of
internal standards for NADPH and UDP-Glc, we were not able to
compare our data with those in the literature. However, UDP-Glc
PAC PAL VAC VAN VG DW
0
1
2
3
4
5
6
7
8
0
10
20
30
40
50
60
70
80
0 10 20 30 40 50 60
M
et
ab
ol
ite
,c
-m
m
ol
/L
Time, h
0
1
2
3
4
5
6
7
8
0
10
20
30
40
50
60
70
80
0 10 20 30 40 50 60
D
W
,g
/L
Time, h
ERGF ERGF
0 2 4 6 8 10 12 14
S-VG
C-VG
S-VG
C-VG
C-mmol/g DW
VG PAC PAL VAC VAN
G
F
E
R
Fig. 5. Metabolic proﬁles of VG and its intermediates in batch cultivation in (a) S-VG and (b) C-VG strains. (c) Accumulation of VG pathway metabolites during the glucose
fermentation (GF) and ethanol respiration (ER) growth phases.
T. Strucko et al. / Metabolic Engineering Communications 2 (2015) 99–108 105
levels were 0.5 mmol/g DW for both strains. These results were also
conﬁrmed by a high resolution mass spectrometer, where similar
chemical proﬁles were obtained for both strains. The NADPH levels
measured in C-VG and S-VG in our study were close to the limit of
detection preventing a comparison between the two strains.
4. Discussion
The importance of Saccharomyces cerevisiae in the development
of novel cell factories is demonstrated by the large number of in-
dustrially relevant substances that can now be produced in this
organism (Kim et al., 2012; Hong and Nielsen, 2012; Nevoigt,
2008). Several laboratory yeast strains have been used for this
purpose with S288c and CEN.PK being the most popular (Hong
and Nielsen, 2012; Canelas et al., 2010). However, despite that the
two strains are genetically and physiologically very different (van
Dijken et al., 2000; Canelas et al., 2010; Otero et al., 2010; Nijkamp
et al., 2012); these differences are rarely used to determine, which
strain background should be chosen as a cell factory for de novo
production of a given compound. In this study, we therefore in-
vestigated whether choice of yeast strain background for produc-
tion of vanillin-β-glucoside (VG) is an issue that can be ad-
vantageously considered. Our ﬁnding that heterologous produc-
tion of VG was dramatically more efﬁcient in an S288c based strain
compared to CEN.PK in both batch and continuous cultivations
demonstrates that this is indeed the case.
Our physiological characterizations of the C-VG and S-VG
strains show that the S-VG strain produces signiﬁcantly more VG
in both batch and continuous cultivations. One explanation could
be a higher ﬂux of carbon into the VG pathway in the S-VG strain.
In agreement with this, both the ﬁrst intermediate in the VG
pathway (PAC) and TCV accumulate to signiﬁcant higher levels
with S-VG as compared to with C-VG during both continuous and
batch cultivations, see Figs. 4 and 7. For batch cultivation, we note
this is true at all time points examined, see Fig. 6.
Carbon for VG production is recruited from the shikimate
pathway, which is a part of the aromatic amino acid biosynthesis
and, which is well characterized in yeast (Teshiba et al., 1986;
Braus, 1991). The pathway is tightly regulated via two 3-deoxy-D-
arabinoheptulosonate 7-phosphate (DAHP) synthase isoenzymes
Aro3 and Aro4, which are feedback inhibited by phenylalanine and
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tyrosine, respectively (Fig. 1). In this context, we note that in the
case of CEN.PK derived strains, the ﬂux through the shikimate
pathway is increased more than four-fold if feedback inhibition is
eliminated (Luttik et al., 2008); and that this feature has been
successfully exploited in a metabolic strategy to increase the yield
of CEN.PK strains producing the plant ﬂavonoid naringenin, which
is derived from phenylalanine and tyrosine (Koopman et al., 2012).
Interestingly, two of the genes in the shikimate pathway, ARO1 and
ARO3, contain ten SNPs that result in amino acid substitutions.
Moreover, a large number of SNPs are distributed in the up- and
downstream regions of the genes in the shikimate pathways. It is
therefore likely that the level and/or activities of enzymes of the
shikimate pathway are different in the two strain backgrounds. In
agreement with this, the available “-omics” datasets presented
by Canelas et al. (2010) show that the intracellular concentration
of shikimic acid (the direct metabolite of 3-DHS) is signiﬁcantly
higher in S288c than in CEN.PK strains at similar conditions in
batch and continuous cultivations. Moreover, they also reported
that under chemostat conditions CEN.PK strains are able to
maintain higher intracellular amino-acid pools, which was sug-
gested, and later shown, to be a result of increased protein turn-
over rate (Hong et al., 2012).
In VG producing strains, we therefore speculate that higher
concentrations of intracellular aromatic amino acids in C-VG might
inhibit Aro3 and Aro4 leading to a decreased ﬂux towards 3-DHS
and consequently to a lower capacity for VG production. When the
genomes of S288c and CEN.PK SNPs were compared, several SNPs
exist in genes encoding for enzymes involved in the amino acid and
aromatic compound metabolism. For example, we have compared
ORFs sequences of several ARO genes in the strains, see Table 5.
Importantly, the gene of the pentafunctional enzyme Aro1 (which is
directly involved in synthesis of 3-DHS) contains 15 SNPs, of which,
seven results in non-synonymous amino acid substitutions. More-
over, the gene of the regulatory protein Aro3 was found to contain
23 SNPs, where three caused amino acid substitutions. It is there-
fore possible that the ﬂux through the shikimate pathway could be
different in the two strain backgrounds.
Other features in the two strain backgrounds could inﬂuence
VG production. For example, in the case of batch cultivation, the
higher VG yields in S-VG strains are mainly created after the dia-
uxic shift. This suggests that the S-VG strain has increased activity
of the aromatic biosynthetic pathway only at respiratory meta-
bolism, which is consistent with the even higher activity in the
glucose limited chemostat cultures. This could be due to a lim-
itation in the supply of erythrose-4-phosphate, a precursor for
aromatic amino acid biosynthesis and an intermediate of the
pentose-phosphate (PP) pathway. In this context, we note that at
fermentative conditions the ﬂux through the PP pathway is much
lower than at respiratory conditions (Frick and Wittmann, 2005).
One feature that could inﬂuence the ﬁnal VG yield is availability
of co-factors that are required to convert PAC to VG. To this end we
note that ATP and UDP-glucose levels seem to be unaffected by the
VG pathway in the two strain backgrounds. Moreover, we have
previously introduced mutations designed to increase the NADPH/
NADP level in the original VG producing strain (S288c background)
and this resulted in higher VG levels showing that cofactor avail-
ability appears limiting. However, we note that in this study, the
organization of the inserted VG pathway genes, including gene copy
numbers, in the producer strain is not known (Brochado et al.,
2010). We did not measure SAM levels in C-VG and S-VG and this
co-factor may vary between the two strains. Similarly, the activity of
the PPTase, EntD, which activates ACAR by covalently attaching
phosphopantheine to the apoenzyme is unknown and may differ in
the two strain backgrounds. Considering the more than 13,000 SNPs
between CEN.PK and S288c, one may also expect that differences in
the global metabolism may inﬂuence VG production. For example,
20 genes in the mitogen-activated protein kinase (MAPK) signaling
pathway contain SNPs resulting in amino acid residue substitutions.
Among those, one is in Cyr1, which changes the activity through the
pathway controlled by the global regulator protein kinase A, PKA
(Nijkamp et al., 2012; Vanhalewyn et al., 1999; Tanaka et al., 1990).
The ability of the two strains to adapt to toxic intermediates,
especially PAL and VAN (Hansen et al., 2009), may also vary and
inﬂuence yields. Even if they do not, accumulation of these inter-
mediates vary slightly in the two strain back grounds and may
therefore differentially inﬂuence VG yields. To this end, we note that
the growth rates for C-VG and S-VG are reduced as compared to the
corresponding strains that do not contain the VG pathway.
Since, the VG yield for S-VG is approximately 20-fold below the
maximum theoretical yield; the effects described above are un-
likely due to carbon being channeled into the VG pathway at the
expense of other destinations and functions. An interesting ques-
tion that still remains to be answered is therefore how the two
strain backgrounds develop as VG producers as yields are im-
proved by e.g. metabolic engineering. Similarly, it would be in-
teresting to address whether some of the obvious genetic differ-
ences pointed out above can be transferred from S-VG to C-VG to
improve the VG yields in the latter.
5. Concluding remarks
We have shown that heterologous production of VG differs
dramatically in two different strain backgrounds. Our analyzes
suggest that for strains like CEN.PK and S288c where high quality
“-omics” datasets are available it may be possible to predict, which
of the two strain backgrounds would be the better producer. As
additional data constantly accumulate we expect that such quali-
ﬁed guesses can be made in an increasingly safe manner. However,
many other less characterized strain backgrounds exist, and it is
likely that one of these strains may be a superior producer of VG.
Rapid construction of strains with genetically comparable setups
for VG production would be desirable. To this end, we have re-
cently shown that multiple genes can be simultaneously in-
tegrated into three different sites in our expression platform in one
step by using three different selectable markers (Jensen and
Strucko, 2013). Similarly, simultaneous integration of multiple
genes have also been achieved via CRISPR-Cas9 technology (Mans
et al., 2015; Jakočiūnas et al., 2015) Importantly, since similar
strain differences are likely to apply for the production of other
metabolites, we strongly recommend to test more than one ge-
netic background during construction of a novel cell factory.
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